EcoLiver’s blood-based test is enabled by a novel platform based on organ-specific Extracellular Vesicles (EVs) for the ...

Groundbreaking longevity research initiative brings together leading scientists and institutions to decode the genetic basis ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...

The Concerto™ System introduces a first-of-its-kind multiplexed, multi-omic digital detection platform, enabling real-time, high-plex quantification of DNA, RNA and protein biomarkers from a single ...

CEOs Gary Smith and Jon Veldhouse discuss renewable materials, traceability and the future of circular fashion.

Mursla Bio, a Cambridge UK and Boston US leader in Extracellular Vesicle (EV) science, has received FDA approval for its lead ...

With the price of eggs skyrocketing, many CPG companies are scrambling for alternatives and while plant-based options have ...

Nvidia CEO Jensen Huang likes to conduct intense ... In the most concrete example, Elon wants to stand on the surface of Mars. That's kind of a science-fiction vision. Working backward, what ...

As part of the event, Timothy Lu, MD, PhD, Chief Executive Officer and Co-Founder ... Circuits can function in T cells, for example Logic Gates that enable selective targeting of solid tumors.

Company expands Intelligent Fingerprinting Drug Screening System multilingual capabilities to meet growing demand across Latin American ...

Pierre Arsène, Founder and CEO of Mursla Bio, said: “This designation is ... of tissue biopsies with the ease of liquid biopsy sample collection, providing a non-invasive intervention with ...